Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Dec 29, 2015
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Regeneron Pharmaceuticals Inc
|
0
|
$302.06 | -$1,977,197.70 |
—
| 6.87K |
Dec 29
|
Scheduled
| ||||||
Regeneron Pharmaceuticals Inc
| 1.92K |
$52.03 | $99,949.63 | +38.85% | 6.87K |
Dec 16
| |||||||
Regeneron Pharmaceuticals Inc
|
0
|
$427.98 | -$1,575,498.00 |
—
| 4.95K |
Aug 5
| |||||||
Regeneron Pharmaceuticals Inc
| 464 |
$344.81 | -$4,359,897.68 | +10.35% | 4.95K |
May 22
| |||||||
Regeneron Pharmaceuticals Inc
| -3.00K |
$416.24 | -$1,248,720.00 | -40.10% | 4.48K |
Feb 27
| |||||||
Regeneron Pharmaceuticals Inc
| 2.8K |
$30.63 | $85,764.00 | +59.82% | 7.48K |
Dec 17
| |||||||
Regeneron Pharmaceuticals Inc
|
0
|
$227.80 | -$3,094,872.70 |
—
| 4.68K |
Dec 15 - Dec 16
|
Scheduled
| ||||||
Regeneron Pharmaceuticals Inc
| 1.68K |
$21.56 | $36,246.53 | +56.03% | 4.68K |
Aug 27
| |||||||
Regeneron Pharmaceuticals Inc
|
0
|
$202.52 | -$1,768,198.75 |
—
| 3K |
Aug 18
|
Scheduled
| ||||||
Regeneron Pharmaceuticals Inc
| 3K |
$21.25 | $63,750.00 |
∞
| 3K |
Feb 20
| |||||||
Regeneron Pharmaceuticals Inc
|
0
|
$177.82 | -$1,712,939.03 |
—
|
0
|
Feb 11
|
Scheduled
| ||||||
Regeneron Pharmaceuticals Inc
| -4.00K |
$290.00 | -$1,160,000.00 | -100.00% |
0
|
Jan 14
|
Scheduled
| ||||||
Regeneron Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Dec 13
| |||||||
Regeneron Pharmaceuticals Inc
|
0
|
$144.90 | -$1,091,235.14 |
—
| 4K |
May 1 - May 2
|
Scheduled
| ||||||
Regeneron Pharmaceuticals Inc
|
0
|
$119.32 | -$1,042,033.38 |
—
| 4K |
Apr 11 - Apr 12
|
Scheduled
| ||||||
Regeneron Pharmaceuticals Inc
|
0
|
$99.34 | -$722,266.04 |
—
| 4K |
Dec 18 - Dec 19
|
Scheduled
| ||||||
Regeneron Pharmaceuticals Inc
| 4K |
$98.00 | -$95,198.00 |
∞
| 4K |
Dec 14 - Dec 17
|
Scheduled
| ||||||
Regeneron Pharmaceuticals Inc
| -256.00 |
$145.23 | -$37,178.88 | -6.00% | 4.01K |
Aug 27
| |||||||
Regeneron Pharmaceuticals Inc
|
0
|
$84.03 | -$1,789,007.59 |
—
|
0
|
Aug 23 - Aug 24
|
Scheduled
| ||||||
Regeneron Pharmaceuticals Inc
|
0
|
$64.99 | -$3,168,418.76 |
—
|
0
|
Feb 14 - Feb 16
| |||||||
Regeneron Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Dec 16
| |||||||
Regeneron Pharmaceuticals Inc
|
0
|
$30.17 | -$208,820.00 |
—
|
0
|
Mar 21
|
Scheduled
| ||||||
Regeneron Pharmaceuticals Inc
|
0
|
$30.16 | -$184,992.00 |
—
|
0
|
Mar 9
|
Scheduled
| ||||||
Regeneron Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Dec 14
| |||||||
Regeneron Pharmaceuticals Inc
|
0
|
$19.48 | -$100,146.25 |
—
|
0
|
Feb 2
|
Scheduled
| ||||||
Regeneron Pharmaceuticals Inc
|
0
|
$15.25 | -$33,156.00 |
—
|
0
|
Dec 18 - Dec 21
|
Scheduled
| ||||||
Regeneron Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Dec 17
| ||||||
Regeneron Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Oct 1
|
Scheduled
| |||||
Regeneron Pharmaceuticals Inc
|
0
|
$17.26 | -$60,261.55 |
—
|
0
| +1 |
Oct 1
|
Scheduled
| |||||
Regeneron Pharmaceuticals Inc
|
0
|
$16.13 | -$51,290.55 |
—
|
0
| +1 |
Oct 1
|
Scheduled
| |||||
Regeneron Pharmaceuticals Inc
|
0
|
$16.40 | -$53,799.61 |
—
|
0
| +1 |
Oct 1
|
Scheduled
| |||||
Regeneron Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| +1 |
Dec 17
| ||||||
Regeneron Pharmaceuticals Inc
|
0
|
$15.05 | -$73,900.27 |
—
|
0
| +1 |
Nov 2
|
Scheduled
| |||||
Regeneron Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.